Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Get coverage of the latest pharmaceutical business developments, and historical metrics on financing, licensing, partnership, and acquisition.
Our trusted Pharma Intelligence brands
Biomedtracker
Get an inside view into the trends powering COVID-era deal making in the life sciences with your free copy of “Biopharma Partnering and Financing Trends, H1 2020”. Informa Pharma Intelligence takes you inside the forces shaping the industry
Topic BIO-Europe
Pharmaprojects
Our world was disrupted at warp speed during 2020. Are you ready to gain a deeper understanding of the year that changed our perceptions of possible?
Medtech Insight
The next-generation TriClip G4 comes in more sizes than the original TriClip and features enhanced leaflet grasping features.
Pink Sheet
The team behind Sputnik V has attacked what it calls “fake news and provocations” in the EU as political arguments over the vaccine claim another ministerial scalp.
Medtech Insight
At last, the EU has reached its milestone of having 20 notified bodies designated under the Medical Device Regulation. And Finland now boasts two.
Scrip
Phase III trials of a number of late-stage investigational therapies are expected to read out during the second quarter of 2021, according to new analysis from Informa Pharma’s product pipeline database Biomedtracker. Some of the Phase III data could be transforming for a few of the less grand players in the pharma sector and here Scrip picks out some of the highlights to look out for in the months ahead.
Generics Bulletin
Guidance published by the US FDA in the form of a question-and-answer document addresses questions from ANDA applicants about generic drug development during the COVID-19 pandemic.
Citeline
Learn about the latest trends affecting biopharma R&D including, study diversity & transparency, predictive feasibility and more...
Scrip
Agreeing that decentralized trials are here to stay, experts discussed in a recent meeting ways in which the pharma research landscape is set to change. With nearly 85% of the industry at different stages of adoption, such trials have seen greater traction in the US, while stricter data privacy laws have hampered progress in Europe, ISCR’s annual conference heard.
Virtually gather healthcare professionals to collaborate on your critical business topics
Recruit experienced investigators or trial-naïve physicians to participate in clinical research. Establish peer-to-peer connections between investigators and physicians after site activation to support patient referrals
Ignite awareness of your clinical trial with featured sponsorships and email campaigns to boost physician awareness and patient enrollment
Scrip
Access Asia Pharma Intelligence expertise and hear from Pharma journalists across Asia to reveal deep regional expertise with this sample of Scrip's Asia 100 Report.
Topic Business Strategies China Company Analysis Drug Development Landscape Market Intelligence
In Vivo
Manufacturing COVID-19 vaccines at unprecedented speed and scale is 2021’s biggest challenge – and mRNA platforms are emerging as the leaders, living up to their promise as the ideal technology for pandemic preparedness.
Citeline Connect
Learn how Citeline Connect supported the fastest-recruiting COVID-19 clinical trial in operation warp speed history
Topic Clinical Trials Coronavirus
Pink Sheet
14 Apr 2021
Pink Sheet
14 Apr 2021
Medtech Insight
14 Apr 2021
Pink Sheet
13 Apr 2021
Pink Sheet
13 Apr 2021
Pink Sheet
13 Apr 2021
Scrip
13 Apr 2021
Generics Bulletin
13 Apr 2021
Pink Sheet
13 Apr 2021
Pink Sheet
13 Apr 2021
Scrip
13 Apr 2021
Medtech Insight
13 Apr 2021
HBW Insight
13 Apr 2021
Generics Bulletin
13 Apr 2021
Pink Sheet
13 Apr 2021
Trialtrove is the go-to resource for clinical trial research. Easily track your competitors' clinical R&D activity with expert insights and continually monitored trials.
Key benefits:
Datamonitor Healthcare's expert coverage of key diseases, companies, drugs and market trends makes it the go-to product for pharmaceutical and biotechnology companies to support the development and validation of their strategic plans and commercial decisions.
Key benefits:
Key benefits:
20 Apr 2021 , 14:00
UK
Webinar
14 Oct 2021 , 18:00
Awards
10 Nov 2021 , 18:00
Awards
Request a live demo
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
How can we help you?
Our team is always happy to hear from you. Please call us at:
Pharma Report Store
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now:
.jpg)
